Patients with chronic kidney disease (CKD) are at high risk for coronary artery disease (CAD), with the probability of developing CAD increasing in a linear fashion as estimated glomerular filtration (eGFR) declines below 60mL/min/1.72m2.1 Cardiovascular disease remains the leading cause of morbidity and mortality among patients with CKD, and yet decisions regarding medical management versus revascularization of CAD have relied heavily on extrapolation of results from the non-CKD population.